Every year the F.D.A. lets onto the market thousands of devices after only cursory review and with no clear evidence that they help patients.

Every year the F.D.A. lets onto the market thousands of devices after only cursory review and with no clear evidence that they help patients.

Sales of the controversial blood test were halted after receiving a warning from the Food and Drug Administration.

The F.D.A. told the company that its blood test to detect ovarian cancer, called OvaSure, requires agency approval before it can be marketed.

The F.D.A. told the company that its blood test to detect ovarian cancer, called OvaSure, requires agency approval before it can be marketed.

Marion Morra is chairwoman of the national board of the American Cancer Society.

Doctors continue to heavily prescribe the cholesterol drug Vytorin, though there is no proof that it helps prolong life or prevent heart attacks.

Doctors continue to heavily prescribe the cholesterol drug Vytorin, though six years after its approval there is still no proof that the drug helps patients live longer or avoid heart attacks.

The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product’s safety.

Amgen is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product’s safety.